Co-treatment With Aripiprazole and Vincristine Sensitizes P-Glycoprotein-Overexpressing Drug-resistant MCF-7/ADR Breast Cancer Cells

CONCLUSION: Co-treatment with low doses of aripiprazole sensitized MCF-7/ADR cells to VIC. Combination therapy with aripiprazole may be a valuable tool for delaying or reducing cancer recurrence by targeting P-gp-overexpressing drug-resistant breast cancer cells.PMID:38423668 | DOI:10.21873/anticanres.16900

Source: Cell Research - February 29, 2024 Category: Cytology Authors: Joo Kyung Shin Hyung Sik Kim Sungpil Yoon Source Type: research